About the journal
Clinical Therapeutics is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,210 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 1879-114X · 0149-2918
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 4,210 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/clinical-therapeutics
Index listings
- MEDLINE · 1980-01-01
- PUBMED · 2014-01-01
- Indexing
- MEDLINE · PUBMED
- APC
- 4,210 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 106 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
8704
Last recorded publication year
2026
h-index
173
i10-index
4083
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 65%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 7706726
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Pharmacogenetics and Drug Metabolism
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical studies and practices
- Diabetes Treatment and Management
- Pharmaceutical Economics and Policy
- Diabetes Treatment and Management
Show all subjects (75)
- Diabetes Treatment and Management
- Pharmacovigilance and Adverse Drug Reactions
- Blood Pressure and Hypertension Studies
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical Practices and Patient Outcomes
- Diabetes Management and Research
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Lipoproteins and Cardiovascular Health
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Statistical Methods in Clinical Trials
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Pharmacy and Medical Practices
- Blood Pressure and Hypertension Studies
- Blood Pressure and Hypertension Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Lysosomal Storage Disorders Research
- Pain Management and Opioid Use
- Diabetes Management and Research
- Diabetes Management and Research
- Antibiotic Use and Resistance
- Lysosomal Storage Disorders Research
- Pharmacogenetics and Drug Metabolism
- Lysosomal Storage Disorders Research
- Pharmacogenetics and Drug Metabolism
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Anesthesia and Pain Management
- Medication Adherence and Compliance
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Glycogen Storage Diseases and Myoclonus
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Asthma and respiratory diseases
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Inflammatory mediators and NSAID effects
- Inflammatory mediators and NSAID effects
- Pharmaceutical industry and healthcare
- Rheumatoid Arthritis Research and Therapies
- Rheumatoid Arthritis Research and Therapies
- Healthcare Policy and Management
- Educational Robotics and Engineering
- Biosimilars and Bioanalytical Methods
- Educational Robotics and Engineering
- Biosimilars and Bioanalytical Methods
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Pneumonia and Respiratory Infections
- Biosimilars and Bioanalytical Methods
- Pneumonia and Respiratory Infections
- Schizophrenia research and treatment
- Antiplatelet Therapy and Cardiovascular Diseases
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ